AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Journal of Neurorestoratology Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Editorial | Open Access

Criticality of an identification standard for mesenchymal stromal cells in clinical investigations

Hongyun Huanga( ), Hari Shanker Sharmab, Paul R. Sanbergc, Lin Chend, Ali Otome, Gustavo A. Movigliaf, Anna Sarnowskag
Cell Therapy Center, Beijing Hongtianji Neuroscience Academy, Beijing 100143, China
Experimental Central Nervous System Injury & Repair, Anesthesiology & Intensive Care Medicine, Department of Surgical Sciences, University Hospital, Uppsala University, Uppsala SE-75185, Sweden
Center of Excellence for Aging & Brain Repair, Department of Neurosurgery & Brain Repair, Morsani College of Medicine, University of South Florida, Tampa 33612, FL, USA
Department of Neurosurgery, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100007, China
Department of Rehabilitation Medicine, Jordan University Hospital, Amman 11183, Jordan
Wake Forest Institute for Regenerative Medicine, Wake Forest University, Winston-Salem 27109, NC, USA
Translational Platform for Regenerative Medicine, Mossakowski Medical Institute, Polish Academy of Science, Warsaw 02-106, Poland
Show Author Information

References

1

Huang HY, Sharma HS, Chen L, et al. Neurorestoratology: new advances in clin-ical therapy. CNS Neurol Disord: Drug Targets. 2023;22(7):1031–1038. https://doi.org/10.2174/1871527321666220827093805.
Crossref Google Scholar
2

Huang HY, Ramon-Cueto A, El Masri W, et al. Advances in Neurorestoratology-Current status and future developments. Int Rev Neurobiol. 2023;171:207–239. https://doi.org/10.1016/bs.irn.2023.04.003.
Crossref Google Scholar
3

Huang HY, Sanberg PR, Moviglia GA, et al. Clinical results of neurorestorative cell therapies and therapeutic indications according to cellular bio-proprieties. Regen Ther. 2023;23:52–59. https://doi.org/10.1016/j.reth.2023.03.004.
Crossref Google Scholar
4

Chen D, Huang HY, Saberi H, et al. Positive and negative cell therapy in ran-domized control trials for central nervous system diseases. Int Rev Neurobiol. 2023;171:241–254. https://doi.org/10.1016/bs.irn.2023.05.017.
Crossref Google Scholar
5

Horwitz EM, le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: the international society for cellular therapy position statement. Cyto-therapy. 2005;7(5):393–395. https://doi.org/10.1080/14653240500319234.
Crossref Google Scholar
6

Kuroda Y, Kitada M, Wakao S, et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci U S A. 2010;107(19): 8639–8643. https://doi.org/10.1073/pnas.0911647107.
Crossref Google Scholar
7

Lo Furno D, Mannino G, Giuffrida R, et al. Neural differentiation of human adipose-derived mesenchymal stem cells induced by glial cell conditioned me-dia. J Cell Physiol. 2018;233(10):7091–7100. https://doi.org/10.1002/jcp.26632.
Crossref Google Scholar
8

Russo C, Mannino G, Patane M, et al. Ghrelin peptide improves glial condi-tioned medium effects on neuronal differentiation of human adipose mesen-chymal stem cells. Histochem Cell Biol. 2021;156(1):35–46. https://doi.org/10.1007/s00418-021-01980-3.
Crossref Google Scholar
9

Shi JM, Yin M. Effect of Wnt/b-catenin signaling pathway in neural differentia-tion of human bone marrow mesenchymal stem cells. Chin J Reparative Reconstr Surg. 2023;37(10):1276–1283. https://doi.org/10.7507/1002-1892.202306017.
Crossref Google Scholar
10

Jaiswal J, Dhayal M. Rapid neurogenic differentiation of human mesenchymal stem cells through electrochemical stimulation. Bioelectrochemistry. 2023;153:108468. https://doi.org/10.1016/j.bioelechem.2023.108468.
Crossref Google Scholar
11

Thrivikraman G, Madras G, Basu B. Electrically driven intracellular and extra-cellular nanomanipulators evoke neurogenic/cardiomyogenic differentiation in human mesenchymal stem cells. Biomaterials. 2016;77:26–43. https://doi.org/10.1016/j.biomaterials.2015.10.078.
Crossref Google Scholar
12

Wu H, Gordon JAR, Whitfield TW, et al. Chromatin dynamics regulate mesen-chymal stem cell lineage specification and differentiation to osteogenesis. Bio-chim Biophys Acta Gene Regul Mech. 2017;1860(4):438–449. https://doi.org/10.1016/j.bbagrm.2017.01.003.
Crossref Google Scholar
13

Xie TQ, Huang QM, Huang QL, et al. Dysregulated lncRNAs regulate human um-bilical cord mesenchymal stem cell differentiation into insulin-producing cells by forming a regulatory network with mRNAs. Stem Cell Res Ther. 2024;15(1): 22. https://doi.org/10.1186/s13287-023-03572-5.
Crossref Google Scholar
14

Dominici M, le Blanc K, Mueller I, et al. Minimal criteria for defining multipo-tent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–317. https://doi.org/10.1080/14653240600855905.
Crossref Google Scholar
15

Wakao S, Kuroda Y, Ogura F, et al. Regenerative effects of mesenchymal stem cells: contribution of muse cells, a novel pluripotent stem cell type that resides in mesenchymal cells. Cells. 2012;1(4):1045–1060. https://doi.org/10.3390/cells1041045.
Crossref Google Scholar
16

Galipeau J, Krampera M, Barrett J, et al. International Society for Cellular Ther-apy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy. 2016;18(2):151–159. https://doi.org/10.1016/j.jcyt.2015.11.008.
Crossref Google Scholar
17

Viswanathan S, Shi Y, Galipeau J, et al. Mesenchymal stem versus stromal cells: international Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy. 2019;21(10):1019–1024. https://doi.org/10.1016/j.jcyt.2019.08.002.
Crossref Google Scholar
18

Viswanathan S, Ciccocioppo R, Galipeau J, et al. Consensus international council for commonality in blood banking automation-international society for cell & gene therapy statement on standard nomenclature abbreviations for the tissue of origin of mesenchymal stromal cells. Cytotherapy. 2021;23(12):1060–1063. https://doi.org/10.1016/j.jcyt.2021.04.009.
Crossref Google Scholar
19

Ueda K, Sato Y, Shimizu S, et al. Systemic administration of clinical-grade mul-tilineage-differentiating stress-enduring cells ameliorates hypoxic-ischemic brain injury in neonatal rats. Sci Rep. 2023;13(1):14958. https://doi.org/10.1038/s41598-023-41026-3.
Crossref Google Scholar
20

Xiang S, Gao W, Peng H, et al. Standards of clinical-grade mesenchymal stromal cell preparation and quality control (2020 China Version). J Neurorestoratol. 2020;8(4):197–216.
Crossref Google Scholar
Journal of Neurorestoratology
Volume 12 Issue 2,
June 2024
Article number: 100115
DOI: 10.1016/j.jnrt.2024.100115
Cite this article:
Huang H, Sharma HS, Sanberg PR, et al. Criticality of an identification standard for mesenchymal stromal cells in clinical investigations. Journal of Neurorestoratology, 2024, 12(2): 100115. https://doi.org/10.1016/j.jnrt.2024.100115

176

Views

1

Crossref

1

Web of Science

1

Scopus

Altmetrics
Received: 23 February 2024
Published: 11 April 2024
© 2024 The Author(s).

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return